Fabricant: FDA Focusing on NDIs, GMPsFabricant: FDA Focusing on NDIs, GMPs
FDA's attention on good manufacturing practices, new dietary ingredients and claims isn't letting up, according to Daniel Fabricant, Ph.D., CEO of the Natural Products Association.
June 13, 2014
FDA's intense focus on good manufacturing practices (GMPs), new dietary ingredients (NDIs) and disease claims is here to stay, according to Daniel Fabricant, Ph.D., CEO of the Natural Products Association (NPA). Fabricant discussed the agency's recent initiatives in his featured presentation Ingredient Marketplace, held on June 2 and 3 in New York City.
This INSIDER News Desk breaks down Fabricant's discussion highlights, including how facility location affects FDA inspections, current NDI statistics and red flag words for disease claims.
For watch Fabricant's presentation in full, register for NPA's webinar "There and Back Again" on June 25.
You May Also Like
Sep 28, 2023
Unlocking vitality: The power of mineral-enriched gummies – articleSep 27, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023